CNH Industrial is not a good buy right now for a beginner long-term investor with available capital who wants to act now. The stock has weak near-term momentum, no strong proprietary buy signal, and mixed-to-negative analyst revisions. Although some analysts still like the name for longer-term recovery potential, the current setup does not offer a clear high-conviction entry. My direct view: hold off for now rather than buy today.
The technical picture is bearish. Price closed at 10.16, only slightly above the 10.15 prior close, but the broader regular-session move was down 2.96%, showing recent weakness. MACD histogram is negative and expanding, indicating downside momentum is still building. RSI_6 at 33.583 is weak but not yet fully oversold. Moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which confirms a downtrend. Key support is near 10.07 and then 9.803, while resistance sits at 10.504 and 10.938. The stock is below pivot resistance and lacks a clear reversal signal.

["Some analysts still maintain Buy/Overweight ratings and target prices above the current share price.", "Truist said CNH markets may be past the bottom, channel inventories are in check, and self-help execution is improving.", "Citi noted positive construction demand trends and a strong pipeline in related end markets.", "Longer-term recovery narrative remains intact if agriculture and construction demand improve."]
["Goldman Sachs downgraded CNH to Neutral from Buy and cut its target to $10.50, citing persistently low North American agricultural demand, macro uncertainty, and higher fertilizer prices.", "Evercore ISI and UBS both lowered price targets recently, reflecting weaker expectations.", "Q1 results reportedly missed consensus EBIT by more than 50%.", "Hedge funds are selling, with selling amount up 125.43% over the last quarter.", "No recent news catalysts in the latest week.", "No AI Stock Picker or SwingMax buy signal is present."]
No detailed quarterly financial snapshot was available, but analyst commentary indicates the latest quarter was weak, especially on EBIT, with a miss of over 50% versus consensus. The market reaction has been cautious, and revisions suggest softer expectations for near-term growth, particularly in agriculture-related demand.
Analyst sentiment is mixed to slightly negative. Recent actions include Goldman downgrading to Neutral with a $10.50 target, Evercore lowering its target to $12.25 with In Line, UBS trimming to $14 but keeping Buy, Bernstein initiating at Market Perform with an $11 target, and Truist maintaining Buy with a lower $16 target. Overall, Wall Street sees some longer-term upside, but the near-term pros and cons view is cautious: bulls point to cyclically improving end markets and execution, while bears focus on weak agriculture demand, macro pressure, and disappointing earnings.